Original Source(s)
Related Content
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min
Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease
In a multicenter registry study, genetic diagnoses were associated with substantially lower cognitive, language, and motor scores; while birth weight, surgical timing, hospitalization burden, and caregiver education were also associated with outcomes.
June 2, 2026
-
3 min
Retinal Imaging AI May Flag Brain Health Risk
Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.
by Kerri Miller
May 29, 2026
-
3 min